Analyst Expectations For Genmab’s Future

Latest Ratings for GMAB

Date Firm Action From To
Feb 2022 SVB Leerink Maintains Market Perform
Jan 2022 HC Wainwright & Co. Upgrades Neutral Buy
Jan 2022 Guggenheim Downgrades Buy Neutral

View More Analyst Ratings for GMAB

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *